A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

Novo, however, vastly underestimated the appetite for its new weight-loss jab. Mr Doustdar says it planned for demand to be three times that of Saxenda, an older and less-effective weight-loss drug.

The U.S. Food and Drug Administration said on Monday it ‍has granted a national priority voucher to Johnson & Johnson's blood ...

The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...

During Q3, the Harbor Capital Appreciation Fund returned 5.11%, underperforming its benchmark, the Russell 1000® Growth Index ...

Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...

Brazilian petrochemical producer Braskem said on Monday that conglomerate Novonor has signed an agreement to sell its controlling stake in the company to private equity firm IG4 Capital.

Some businesses have figured out how to take advantage of an expanded government presence in their boardrooms.

The latest huge capital haul has come to Lightspeed Venture Partners. The 25-year-old venture firm announced Monday that it ...